KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Corrigendum to 'Health-related quality of life in patients with advanced well-differentiated pancreatic and extrapancreatic neuroendocrine tumors treated with surufatinib versus placebo: Results from two randomized, double-blind, phase III trials (SANET-p and SANET-ep)' [European Journal of Cancer 169 (2022) 1-9].

Jiarui Li, Yuejuan Cheng, Chunmei Bai, Jianming Xu, Lin Shen, Jie Li, Zhiwei Zhou, Zhiping Li, Yihebali Chi, Xianjun Yu, Enxiao Li, Nong Xu, Tianshu Liu, Wenhui Lou, Yuxian Bai, Xianglin Yuan, Xiuwen Wang, Ying Yuan, Jia Chen, Sha Guan, Songhua Fan, Weiguo Su

Eur J Cancer 178 247-248

PMID36402625
PMCID-
DOI10.1016/j.ejca.2022.10.001
发表日期2022-11-19
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。